Heterotopic ossification (HO) refers to the pathologic formation of mature lamellar bone in soft tissue following trauma, surgery, severe burns, neurologic injury, or prolonged inflammation. Men are more susceptible to HO, and other risk factors for HO include a history of hip arthroplasty or a previous occurrence of HO. The anatomical sites commonly prone to HO include hips, knees, and shoulders. However, HO may also develop in the elbows, ankles, and other bone joints in the human body.
Although there is sufficient information on the prophylaxis for heterotopic ossification, there has been limited research on the treatment of established HO. This article describes a case of successful management of established HO in a COVID-19 patient with contraindication for non-steroidal anti-inflammatory drugs (NSAIDs). Case presentation A 59-year-old male patient presented with dyspnea. He was…
